Colon cancer rates for people under age 50 are going up across countries both rich and poor. In the US, rates for older adults are declining, while early-onset colon cancer is on the rise.

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...

Colorectal cancer cases are increasing, especially among young adults under 55, with lifestyle and environmental factors possibly playing a role. While changes in bowel habits, including pencil ...

Colon cancer is quickly becoming a young person's disease in countries around the world. A new study released Wednesday in the Lancet Oncology documents rising rates of early-onset colorectal ...

Please note, the data displayed for this chart reflects the title's midweek position only, peak positions on this chart also relate to midweek chart positions. Official Singles Chart Update data ...

EXEL's shares surge 50% in a year on the back of the strong performance of its lead drug Cabometyx. We are optimistic about ...

America's ultraprocessed diet may be a key culprit behind rising colon cancer rates in younger adults, a new study suggests. The study in the journal Gut found higher levels of inflammation in ...

Colon cancer cases are increasing, particularly among young adults. Poor diet, lack of exercise, and unhealthy habits contribute to this rise. A healthy diet rich in fiber, protein, dairy ...

lucky night chart FDA's emergency use authorization process is gradually improving and should be more transparent Moderna combo misses clinical endpoint for colorectal cancer but shows promise in head ...

The greatest annual increases were in New Zealand, Chile and Puerto Rico MONDAY, Dec. 16, 2024 (HealthDay News) -- More young people around the world are falling prey to colon cancer, a new study ...

satta chart disawar satta chart Losing medical insurance support! Ascletis's half-year performance fell 57.8% and R&D investment decreased 19.4% Keytruda gets FDA approval as first-line monotherapy ...